PURPOSE: To develop a noninvasive MRI method for determining the germination and infection of tumor-homing bacteria in bacteriolytic cancer therapy using endogenous CEST contrast. METHODS: The CEST parameters of the anaerobic gram-positive bacterium Clostridium novyi-NT (C. novyi-NT) were first characterized in vitro, then used to detect C. novyi-NT germination and infection in subcutaneous CT26 colorectal tumor-bearing mice (n = 6) after injection of 300 million bacterial spores. Lipopolysacharide (LPS) injected mice were used to exclude that the changes of CEST MRI were due to inflammation. RESULTS: CEST contrast was observed over a broad frequency range for bacterial suspensions in vitro, with the maximum contrast around 2.6 ppm from the water resonance. No signal could be detected for bacterial spores, demonstrating the specificity for germination. In vivo, a significant elevation of CEST contrast was identified in C. novyi-NT infected tumors as compared to those before bacterial germination and infection (P < 0.05; n = 6). No significant change was observed in tumors with LPS-induced sterile inflammation (P > 0.05; n = 4). CONCLUSION: Endogenous bacterial CEST contrast (bacCEST) can be used to monitor the germination and proliferation of the therapeutic bacterium C. novyi-NT without a need for exogenous cell labeling probes.
PURPOSE: To develop a noninvasive MRI method for determining the germination and infection of tumor-homing bacteria in bacteriolytic cancer therapy using endogenous CEST contrast. METHODS: The CEST parameters of the anaerobic gram-positive bacterium Clostridium novyi-NT (C. novyi-NT) were first characterized in vitro, then used to detect C. novyi-NT germination and infection in subcutaneous CT26colorectal tumor-bearing mice (n = 6) after injection of 300 million bacterial spores. Lipopolysacharide (LPS) injected mice were used to exclude that the changes of CEST MRI were due to inflammation. RESULTS: CEST contrast was observed over a broad frequency range for bacterial suspensions in vitro, with the maximum contrast around 2.6 ppm from the water resonance. No signal could be detected for bacterial spores, demonstrating the specificity for germination. In vivo, a significant elevation of CEST contrast was identified in C. novyi-NTinfected tumors as compared to those before bacterial germination and infection (P < 0.05; n = 6). No significant change was observed in tumors with LPS-induced sterile inflammation (P > 0.05; n = 4). CONCLUSION: Endogenous bacterial CEST contrast (bacCEST) can be used to monitor the germination and proliferation of the therapeutic bacterium C. novyi-NT without a need for exogenous cell labeling probes.
Authors: Xiaolei Song; Assaf A Gilad; Suresh Joel; Guanshu Liu; Amnon Bar-Shir; Yajie Liang; Michael Gorelik; James J Pekar; Peter C M van Zijl; Jeff W M Bulte; Michael T McMahon Journal: Magn Reson Med Date: 2012-01-13 Impact factor: 4.668
Authors: Chetan Bettegowda; Catherine A Foss; Ian Cheong; Yuchuan Wang; Luis Diaz; Nishant Agrawal; James Fox; James Dick; Long H Dang; Shibin Zhou; Kenneth W Kinzler; Bert Vogelstein; Martin G Pomper Journal: Proc Natl Acad Sci U S A Date: 2005-01-14 Impact factor: 11.205
Authors: Guanshu Liu; Assaf A Gilad; Jeff W M Bulte; Peter C M van Zijl; Michael T McMahon Journal: Contrast Media Mol Imaging Date: 2010 May-Jun Impact factor: 3.161
Authors: Ping H Lai; Jih T Ho; Wei L Chen; Shu S Hsu; Jyh S Wang; Huay B Pan; Chien F Yang Journal: AJNR Am J Neuroradiol Date: 2002-09 Impact factor: 3.825
Authors: Nishant Agrawal; Chetan Bettegowda; Ian Cheong; Jean-Francois Geschwind; Charles G Drake; Edward L Hipkiss; Mitsuaki Tatsumi; Long H Dang; Luis A Diaz; Martin Pomper; Mohammad Abusedera; Richard L Wahl; Kenneth W Kinzler; Shibin Zhou; David L Huso; Bert Vogelstein Journal: Proc Natl Acad Sci U S A Date: 2004-10-07 Impact factor: 11.205
Authors: Scott M Knudsen; Nathan Cermak; Francisco Feijó Delgado; Barbara Setlow; Peter Setlow; Scott R Manalis Journal: J Bacteriol Date: 2015-10-19 Impact factor: 3.490
Authors: David Ryoo; Xiang Xu; Yuguo Li; Joel A Tang; Jia Zhang; Peter C M van Zijl; Guanshu Liu Journal: Anal Chem Date: 2017-07-05 Impact factor: 6.986
Authors: Jing Liu; Renyuan Bai; Yuguo Li; Verena Staedtke; Shuixing Zhang; Peter C M van Zijl; Guanshu Liu Journal: Magn Reson Med Date: 2018-03-25 Impact factor: 4.668
Authors: Yuguo Li; Hanwei Chen; Jiadi Xu; Nirbhay N Yadav; Kannie W Y Chan; Liangping Luo; Michael T McMahon; Bert Vogelstein; Peter C M van Zijl; Shibin Zhou; Guanshu Liu Journal: Oncotarget Date: 2016-02-09